Market: NMS |
Currency: USD
Address: 3600 Green Court
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
📈 ENDRA Life Sciences Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$30.00
-
Upside/Downside from Analyst Target:
574.16%
-
Broker Call:
2
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
50-100%
-
Net Income Growth Range (1Y):
0-10%
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for ENDRA Life Sciences Inc.
| Date | Reported EPS |
|---|
| 2026-03-31 | -2.23 |
| 2025-11-14 | -2.1 |
| 2025-08-14 | -1.71 |
| 2025-05-15 | -1.86 |
| 2025-03-31 | 25.2 |
| 2024-11-15 | -9.54 |
| 2024-08-14 | -140 |
| 2024-05-14 | -455 |
| 2024-03-28 | -297.5 |
| 2023-11-14 | -700 |
| 2023-08-14 | -752.5 |
| 2023-05-15 | -1627.5 |
| 2023-03-14 | -1680 |
| 2022-11-14 | -1750 |
| 2022-08-15 | -2100 |
| 2022-05-12 | -2450 |
| 2022-03-30 | -2975 |
| 2021-11-15 | -2100 |
| 2021-08-12 | -2800 |
| 2021-05-17 | -2100 |
| 2021-03-25 | -7700.01 |
| 2020-11-16 | -5250.01 |
| 2020-08-14 | -7000.01 |
| 2020-05-14 | -10150.01 |
| 2020-03-26 | -42000.04 |
📰 Related News & Research
No related articles found for "endra life".
